LISVOAY
Live / Applied — Response to non-final action entered (as of 25 Mar 2026)
What this means for you
Not registered yet, but its 21 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99294595
- Mark type
- Stylized text
- Filed
- 21 Jul 2025
- Attorney of record
- Eric R. Moran
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin lispro; insulin analog; anti-diabetic pharmaceuticals; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin lispro; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin lispro; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetic pharmaceuticals
Owner
- Hong Kong King-Friend, Industrial Company, Ltd., Mongkok, Kowloon, HK
Prosecution history
- 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 25 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Sept 2025 — NON-FINAL ACTION E-MAILED
- 25 Sept 2025 — NON-FINAL ACTION WRITTEN
- 24 Sept 2025 — ASSIGNED TO EXAMINER
- 21 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jul 2025 — NEW APPLICATION ENTERED